Springer Health+ IME (@SpringerIME)
@SpringerIME
Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.
2.8K 正在关注 18.7K 粉丝
From emerging therapies to tactics for multidisciplinary collaboration, this free, CME-accredited video podcast series combines expert insights with the latest scientific data to increase your clinical confidence in the management of generalized myasthenia gravis.
显示更多
New phase 2 trial findings published in The Lancet Diabetes & Endocrinology suggest burosumab treatment for X-linked hypophosphataemia (XLH) may begin in the first year of life. Unpick the findings in our latest article.
显示更多
